Trexquant Investment LP Care Dx, Inc. Transaction History
Trexquant Investment LP
- $8.01 Billion
- Q1 2025
A detailed history of Trexquant Investment LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 309,743 shares of CDNA stock, worth $3.71 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
309,743
Previous 333,876
7.23%
Holding current value
$3.71 Million
Previous $7.15 Million
23.1%
% of portfolio
0.07%
Previous 0.09%
Shares
25 transactions
Others Institutions Holding CDNA
# of Institutions
229Shares Held
56.8MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$63.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$57.9 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$31.9 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$29.7 Million0.0% of portfolio
-
Bamco Inc New York, NY2.19MShares$26.2 Million0.12% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $640M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...